Spray Away Pain? How Lidocaine Could Change Endometrial Biopsies
"New research suggests a simple lidocaine spray might significantly reduce discomfort during outpatient endometrial sampling. Is this the future of pain management in gynecology?"
For women over 35, abnormal vaginal bleeding is a common and often distressing issue, potentially signaling various conditions from treatable infections to more serious concerns like endometrial cancer. A crucial step in diagnosis is often an endometrial biopsy, a procedure that, despite its necessity, can cause significant pain and anxiety.
Traditionally, pain management during endometrial biopsies has involved methods ranging from oral analgesics to more invasive techniques like cervical injections. However, a recent study conducted at Thammasat University Hospital in Thailand suggests a simpler, less invasive approach: a topical lidocaine spray. This research investigates whether a quick spray of lidocaine can effectively minimize pain during the procedure, potentially improving patient comfort and acceptance.
This article will delve into the findings of this randomized, placebo-controlled trial, exploring how lidocaine spray compares to traditional methods and what implications this could have for women undergoing endometrial biopsies. We'll break down the study's methodology, results, and potential benefits, offering a clear understanding of whether lidocaine spray could be the future of pain relief in outpatient gynecology.
Pain-Control Options for Endometrial Biopsy
A 2019 review describes intrauterine anesthetics, cervical anesthetic spray, paracervical block, and oral NSAIDs as methods used for pain control during outpatient endometrial biopsy. It reports that paracervical block and NSAIDs were associated with significant pain reduction compared with placebo in most of the related studies. A 2024 prospective, randomized, observational study set out to compare intrauterine lidocaine, oral dexketoprofen, cervical lidocaine spray, and a paracervical block with prilocaine. The sources identify multiple approaches but do not establish one as universally preferable.
Studies of Topical Lidocaine
A 2018 randomized placebo-controlled trial investigated whether lidocaine spray could reduce pain during endometrial biopsy in women aged 35 or older with abnormal vaginal bleeding. A separate study reported that cervical lidocaine gel appeared effective at reducing pain during Pipelle endometrial biopsy, with a significant reduction in pain experienced during curettage after the procedure. In 2019, researchers described a study comparing lidocaine spray with placebo and no intervention for endometrial aspiration biopsy. Together, these studies examined different topical forms and application approaches; the supplied information does not establish a single milestone or definitive progression.
Lidocaine Spray: A Game-Changer for Biopsy Pain?
The study, involving 140 participants, compared the use of 10% lidocaine spray to a placebo (saline spray) in women undergoing outpatient endometrial biopsies using the Novak curette method. The participants, nurses, and gynecologists were all blinded to which spray was being used. The lidocaine group received four puffs of the spray on the cervix three minutes before the procedure.
- Tenaculum Application: Only 12.8% of the lidocaine group reported severe pain compared to 28.5% in the placebo group.
- Novak Curette Insertion: The percentage of participants experiencing severe pain dropped from 55.7% in the control group to 38.5% in the lidocaine group.
- Tissue Aspiration: A significant decrease in severe pain was noted, with 60% in the lidocaine group versus 78.5% in the placebo group.
Recent Trials and Review
A randomized controlled trial at Phrae Hospital examined 10% lidocaine spray for endometrial sampling with a Wallach Endocell; it was conducted in the gynecology outpatient department from October 2023 to February 2024 and was listed as published August 31, 2026. A separate three-arm, placebo-controlled trial at Nakornping Hospital compared 2% lidocaine gel, 10% lidocaine spray, and placebo in women aged 35 or older undergoing office-based sampling; the study ran from February to September 2025 and was listed September 3, 2026. A 2026 narrative review identifies NSAIDs, lidocaine gel, lidocaine spray, and paracervical blocks as common pharmacological methods for outpatient gynecological procedures. The supplied summaries describe the research questions and methods, but do not provide trial results.
Subjective Pain Measurement
The randomized placebo-controlled trial of lidocaine spray for outpatient endometrial sampling identifies subjective variation in pain among patients as its main limitation. Because pain is assessed as a patient experience, differences between individuals complicate interpretation of the study’s findings. The supplied source does not specify the size or direction of any effect attributable to that limitation.
A Simpler, Kinder Future for Endometrial Biopsies?
The findings of this study offer a promising step forward in improving the patient experience during endometrial biopsies. By demonstrating that a simple lidocaine spray can significantly reduce pain during key moments of the procedure, this research opens the door for more comfortable and less anxiety-ridden outpatient gynecology visits.
Mixed Evidence on Cervical Spray
A report indexed by PubMed concludes that lidocaine spray applied to the cervix is not effective for reducing pain associated with Pipelle endometrial aspiration biopsy. The accompanying study is identified as a randomized controlled trial by Ratpaporn Piyawetchakarn and Kittipat Charoenkwan of Chiang Mai University’s Department of Obstetrics and Gynecology in Chiang Mai, Thailand. This finding concerns cervical spray for Pipelle aspiration biopsy specifically; the supplied sources do not support extending it to every lidocaine formulation or biopsy setting.
A Trial in Outpatient Practice
A randomized controlled trial at the gynecology outpatient department of Phrae Hospital investigated whether 10% lidocaine spray could reduce pain during endometrial sampling using a Wallach Endocell. The study took place from October 2023 to February 2024. The supplied source describes the trial’s aim, setting, device, and dates, but does not report its results or broader barriers to adopting pain-control methods.
Pain During and After Sampling
In a randomized placebo-controlled trial of outpatient endometrial sampling, the study group received 10% topical lidocaine spray, a 40 mg dose, before endometrial aspiration. A report of the study says the groups did not differ significantly in postoperative pain at 15 minutes or two hours. The same report indicates that topical spray can relieve pain during endometrial tissue sampling, so its reported benefit concerns pain during the procedure rather than those later postoperative measurements.
Compared to more invasive pain management techniques, lidocaine spray offers a non-invasive, cost-effective, and easily administered solution. This could lead to increased patient acceptance of endometrial biopsies, ultimately facilitating earlier diagnosis and treatment of potentially serious conditions.
While further research may be needed to optimize the application and duration of lidocaine's effects, this study provides strong evidence that a simple spray can make a significant difference in women's health. It's a testament to the power of innovative thinking in addressing common concerns and improving the overall quality of care.